Skip to main content
. 2014 Aug 25;17(2):243–253. doi: 10.1093/neuonc/nou217

Fig. 1.

Fig. 1.

SMO expression in glioma specimens and cell lines correlated with poor survival. (A) SMO expression in glioma specimens and normal brain tissues as assessed by qRT-PCR. (B) SMO expression in different grade gliomas between peritumor tissues and tumor tissues by Western blot assay. (C) qRT-PCR analysis showed T98G, SHG44, U251, and U251-TSC glioma cells expressed higher levels of SMO than the Olig cell line. The data represent mean ± SE of 3 replicates (*P < .05). (D) Kaplan–Meier survival curves indicating cumulative survival as a function of time for those patients with SMO high expression versus low expression. The patients with high SMO expression experienced a significantly worse outcome (*P < .05).